BioAdaptives Inc.
BDPT - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$21.29K
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $21,289.00 |
|---|---|
| Enterprise Value | $514,793.00 |
| Earnings per Share | $-0.15 |
| Beta | 1.09 |
| Outstanding Shares | 14,192,536 |
Return
| Return on Equity | 65.91% |
|---|---|
| Return on Assets | -1477.75% |
| Return on Invested Capital | 77.67% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 20.14 |
| Enterprise Value to EBIT | -0.38 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.02 |
| Debt to Equity | -0.3 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 19, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BioAdaptives Inc.
1 employees
CEO: James Keener
BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and incl...